• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIOMED GMBH & CO. MEDIZINTECHNIK KG FLUENCY PLUS VASCULAR STENT GRAFT; VASULAR STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIOMED GMBH & CO. MEDIZINTECHNIK KG FLUENCY PLUS VASCULAR STENT GRAFT; VASULAR STENT GRAFT Back to Search Results
Catalog Number FVM09100
Device Problems Break (1069); Difficult or Delayed Positioning (1157); Fracture (1260); Detachment of Device or Device Component (2907)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Type  malfunction  
Manufacturer Narrative
The catalog number identified has not been cleared in the us but is similar to the fluency plus endovascular stent graft products that are cleared in the us.The product classification code for the fluency plus endovascular stent graft product is identified.The lot number for the malfunction was provided and a lot history review will be performed.The device for this malfunction has been returned to the manufacturer for evaluation.The investigation of the reported malfunction is currently underway.The device is labeled for single use.(b)(4).
 
Event Description
This report summarizes one malfunction.A review of the reported information indicated that model fvm091100 vascular stent graft allegedly experienced break, detachment of device or device component, difficult or delayed positioning and fracture.This information was received from one source.This malfunction involved one patient with no consequences.The patient's age, weight and gender were not provided.
 
Event Description
This report summarizes one malfunction.A review of the reported information indicated that model fvm091100 vascular stent graft allegedly experienced break, detachment of device or device component, difficult or delayed positioning and fracture.This information was received from one source.This malfunction involved one patient with no consequences.The patient's age, weight and gender were not provided.
 
Manufacturer Narrative
The catalog number identified has not been cleared in the us but is similar to the fluency plus endovascular stent graft products that are cleared in the us.The product classification code for the fluency plus endovascular stent graft product is identified.The lot number for the malfunction was provided and a lot history review was performed.The device for this malfunction was returned to the manufacturer for evaluation.The investigation is confirmed for fracture, however break and detachment could not be identified.A definite root cause for the reported issue could not be determined.The device is labeled for single use.The information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FLUENCY PLUS VASCULAR STENT GRAFT
Type of Device
VASULAR STENT GRAFT
Manufacturer (Section D)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstrasse 6
karlsruhe 76227
GM  76227
MDR Report Key9955645
MDR Text Key187529624
Report Number9681442-2020-00107
Device Sequence Number1
Product Code PFV
UDI-Device Identifier00801741145704
UDI-Public(01)00801741145704
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Type of Report Initial,Followup
Report Date 06/29/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Catalogue NumberFVM09100
Device Lot NumberANCR0785
Initial Date Manufacturer Received 03/31/2020
Initial Date FDA Received04/13/2020
Supplement Dates Manufacturer Received06/26/2020
Supplement Dates FDA Received06/29/2020
Patient Sequence Number1
-
-